Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Public Health Research. 2018, 6(2), 62-62
DOI: 10.12691/AJPHR-6-2-7
Special Issue

Will Precision Medicine Ever be A Possibility for Controlling Tuberculosis?

Somchai Bovornkitti1,

1The Academy of Science, The Royal Society of Thailand

Pub. Date: March 22, 2018
(This article belongs to the Special Issue Tuberculosis and Respiratory Diseases Among Silica and Other Dust Exposed Workers)
Full Text PDF

Cite this paper

Somchai Bovornkitti. Will Precision Medicine Ever be A Possibility for Controlling Tuberculosis?. American Journal of Public Health Research. 2018; 6(2):62-62. doi: 10.12691/AJPHR-6-2-7

Abstract

Keywords

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Bovornkitti, S. Tuberculosis situation in Thailand is deteriorating! Thammasat Medical Journal, 17: 669. 2017.
 
[2]  Pitukpakorn, M., Bovornkitti, S. Molecular Medicine. Buddhachinaraj Medical Journal, 33: 246-254.2016
 
[3]  Pitukpakorn, M., Bovornkitti, S. Susceptibility factors in the genesis of mesothelioma. Buddhachinaraj Medical Journal, 33: 255-257. 2016.
 
[4]  Huang, S.X.L., Jaurand, M.C., Kamp, D.W., Whysner, J., Hei, T.K. Role of mutagenicity in mineral fiber-induced carcinogenicity and other diseases. Journal of Toxicology and Environmental Health, 14(Part B): 179-245. 2011.
 
[5]  Li, C.M., Cambell, S.J., Kumararatne, D.S., Bellamy, R., Ruwende, C., McAdam, K.P.W.J., et al. Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. The Journal of Infectious Diseases, 186 (10) : 1458-1462.2002
 
[6]  Yim, J-J., Lee, H.W., Lee, H.S., Kim, Y.W., Han, S.K., Shim, Y-S., Holland, S.M. The association between microsatellite polymorphisms in intron II of human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes and Immunity, 7: 150-155. 2006.
 
[7]  Azad, A.K., Sadee, W., Schlesinger, L.S. Innate immune gene polymorphisms in tuberculosis. Infection and Immunity, 80 (10) : 3343-3359. 2012.
 
[8]  Blischak, J.D., Tailleux, L., Myrthil, M.,Charlois, C., Bergot, E., Dinh, A., et al. Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells. Scientific Reports 7, Article number: 5702(2017). [online] Available at: https//www.nature.com/articles/s41598-017-05878-w. [Accessed 16 November 2017].
 
[9]  Pitukpakorn, M., Bovornkitti, S. Molecular Scissors. Buddhachinaraj Medical Journal, 33: 241-243.2016.
 
[10]  Pitukpakorn, M., Bovornkitti, S. CRISPR/Cas: The Molecular Scissors. Thammasat Medical Journal, 17: 458-461. 2017.